Novartis receives FDA approval for Mayzent (siponimod), the first oral drug to treat secondary progressive MS with active disease Read more
Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China Read more
FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer Read more
Data from GARNET study indicates robust activity of dostarlimab in patients with advanced or recurrent endometrial cancer Read more
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD Read more
Iktos Announces Collaboration with Merck for Use of Iktos AI Technology across Three Drug Discovery Projects Read more
EC approves Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors Read more